Who Owns InMed Pharmaceuticals Stock?
NASDAQ: INMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 52.16%
- Held by insiders
- 0.06%
- Institutional holders
- 22
- Institutions 52.2%
- Insiders 0.1%
- Public and other 47.8%
Who owns InMed Pharmaceuticals stock?
Institutional investors own about 52.2% of InMed Pharmaceuticals's shares, spread across 22 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 0.06% of INM.
The largest institutional holders are Adar1 Capital Management, LLC (14.56%), Vivo Capital, LLC (14.53%) and Squadron Capital Management LLC (5.92%). Together, the top 10 institutions control 47.1% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their INM positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of INM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Adar1 Capital Management, LLC | 800.00K | 14.56% | +100.0% |
| Vivo Capital, LLC | 798.38K | 14.53% | +100.0% |
| Squadron Capital Management LLC | 325.00K | 5.92% | +100.0% |
| Ikarian Capital, LLC | 245.03K | 4.46% | +100.0% |
| Ursa Fund Management, LLC | 125.80K | 2.29% | +100.0% |
| Montanova Capital LLC | 100.00K | 1.82% | +100.0% |
| Boothbay Fund Management, LLC | 74.24K | 1.35% | +100.0% |
| Sabby Management, LLC | 44.97K | 0.82% | -79.6% |
| Jane Street Group, LLC | 43.08K | 0.78% | +100.0% |
| Venrock Adviser, LLC | 32.69K | 0.59% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of INM
| Fund | Shares | % Held |
|---|---|---|
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 6.50K | 0.12% |
Frequently asked questions
Who is the largest shareholder of InMed Pharmaceuticals?
Adar1 Capital Management, LLC is the largest institutional shareholder of INM, owning 14.56% of shares outstanding (800.00K shares) as of its latest 13F filing.
What percentage of InMed Pharmaceuticals is owned by institutions?
Institutions own about 52.2% of INM shares and 52.2% of the public float.
How much of InMed Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.06% of INM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.